Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
19 hedge funds and large institutions have $1.47M invested in Bio-Path Holdings Inc in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 1 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
12% more funds holding
Funds holding: 17 → 19 (+2)
8% less capital invested
Capital invested by funds: $1.59M → $1.47M (-$128K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MYIA
Mount Yale Investment Advisors
Denver,
Colorado
|
+$96.3K |
| 2 |
VF
Virtu Financial
New York
|
+$45.9K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$41.4K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$13.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$8.51K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$33.6K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$1K |
BPTH Hedge Fund Activity: Q3 2022 in Review
19 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2022, worth a combined $1.47M — down 8% from $1.59M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new BPTH positions and 1 closed out — a net gain of 2 holders — while 5 added to existing stakes and 1 trimmed.
The largest buyer was Mount Yale Investment Advisors, opening a new position worth an estimated $96.3K. The largest seller was Morgan Stanley, cutting an estimated $33.6K.
- 19 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2022, up from 17 in Q2 2022.
- Funds reported $1.47M of Bio-Path Holdings Inc stock for Q3 2022, down 8% quarter-over-quarter.
- 3 funds opened new Bio-Path Holdings Inc positions in Q3 2022 and 1 closed out, a net change of +2 holders.
- The largest Bio-Path Holdings Inc buyer in Q3 2022 was Mount Yale Investment Advisors, an estimated $96.3K added.
- The largest Bio-Path Holdings Inc seller in Q3 2022 was Morgan Stanley, an estimated $33.6K sold.
Based on aggregated 13F filings for Q3 2022.